GLIMMERS: glioma molecular markers exploration using long-read sequencing

Area of Science:

• Genomics
• Oncology
• Bioinformatics

Background:

• Revised World Health Organization (WHO) guidelines for brain tumor classification incorporate copy number variation (CNV) markers.
• Nanopore sequencing offers rapid, genome-wide CNV detection but requires complex bioinformatics expertise.
• Current CNV analysis methods present barriers for clinicians due to time and resource demands.

Purpose of the Study:

• To develop an accessible tool for analyzing nanopore-based CNV data for brain tumor classification.
• To simplify the interpretation of CNV markers for non-bioinformaticians.
• To facilitate the clinical application of genomic markers in glioma grading.

Main Methods:

• Development of GLIMMERS (glioma molecular markers exploration using long-read sequencing), an open-access software tool.
• Automated analysis of nanopore sequencing data for copy number variations.
• Generation of simplified reports for clinical interpretation.

Main Results:

• GLIMMERS automates the detection and analysis of CNVs from long-read sequencing data.
• The tool significantly reduces the complexity and time required for CNV marker interpretation.
• Simplified reports enable clinicians to more easily classify and grade brain tumors.

Conclusions:

• GLIMMERS addresses the need for user-friendly bioinformatics tools in clinical oncology.
• The software facilitates the integration of genomic CNV data into routine brain tumor diagnostics.
• GLIMMERS enhances the practical application of updated WHO classification guidelines for brain tumors.